Selective in vivo radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells transduced with the E. Coli cytosine deaminase (CD) gene

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 4, 1998, Pages 883-887

  Gabel, M ^a   Kim, J H ^a   Kolozsvary, A ^a   Khil, M ^a   Freytag, S ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Cancer gene therapy; Cytosine deaminase; Radiosensitization

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL GENE; CANCER INHIBITION; CANCER RADIOTHERAPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIZATION; SUBCUTANEOUS DRUG ADMINISTRATION; SUICIDE GENE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CYTOSINE DEAMINASE; ESCHERICHIA COLI; FEMALE; FLUCYTOSINE; FLUOROURACIL; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED STRAINS; MICE, NUDE; NUCLEOSIDE DEAMINASES; PRODRUGS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE;

EID: 0031803611     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00125-4     Document Type: Article

References (24)

1. Austin E.A., Huber B.E. A first step in the development of gene therapy for colorectal carcinoma Cloning, sequencing, and expression of Escherichia coli cytosine deaminase . Mol. Pharmacol. 43:1993;380-387.
2. Bi, W. L.; Parysek, L. M.; Warnick, R.; Stambrook, P. J. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gener therapy. Hum. Gene Ther. 4:725-531; 1993.
3. Culver K.W., Ram Z., Wallbridge S., Ishii H., Oldfield E.H., Blaese R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1992;1550-1552.
4. Emerman M., Temin H.M. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell. 39:1984;459-467.
5. Freeman S.M., Abboud C.N., Whartenby K.A., Packman C.H., Koeplin D.S., Moolten F.L., Abraham G.N. The "bystander effect" Tumor regression when a fraction of the tumor mass is genetically modified . Cancer Res. 53:1993;5274-5283.
6. Hanna N.N., Mauceri H.J., Wayne J.D., Hallahan D.E., Kufe D.W., Weichselbaum R.R. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts. Cancer Res. 57:1997;4205-4209.
7. Hirchowitz E.A., Ohwada A., Pascal W.R., Russi T.J., Crystal R.G. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6:1995;1055-1063.
8. Huber B.E., Austin E.A., Good S.S., Knick V.C., Tibbels S., Richards C.A. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53:1993;4619-4626.
9. Huber B.E., Austin E.A., Richards C.A., Davis S.T., Good S.S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase . Proc. Natl. Acad. Sci. USA. 91:1994;8302-8306.
10. Kanai F., Lan K.H., Shiratori Y., Tanako T., Ohashi M., Okudaira T., Yashida Y., Wakimoto H., Hamado H., Nakabayashi H., Tamaoki T., Omata M. In vivo gene therapy for a-fetoprotein-cytosine deaminase gene. Cancer Res. 57:1997;461-465.
11. Khil M.S., Kim J.H., Mullen C.A., Kim S.H., Freytag S.O. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene. Clin. Cancer Res. 2:1996;53-57.
12. Kim J.H., Kim S.H., Brown S.L., Freytag S.O. Selective enhancement by an antiviral agent of the radiation induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res. 54:1994;6053-6056.
13. Mullen C.A., Coale M.M., Lowe R., Blaese R.M. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res. 54:1994;1503-1506.
14. Mullen C.A., Kilstrup M., Blaese R.M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine A negative selection system. Proc . Natl. Acad. Sci. USA. 89:1992;33-37.
15. Ohwada A., Hirschowitz E.A., Crystal R.G. Regional delivery of an adenovirus vector containing the Escheria coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Hum. Gene Ther. 7:1996;1567-1576.
16. Roth A.J., Cristiano R.J. Gene therapy for cancer What have we done and where are we going? J. Natl. Cancer Inst. 89:1997;21-39.
17. Bruso C.E., Shewach D.S., Lawrence T.S. Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;1411-1417.
18. Byfield J.E. Combined use of drugs and radiation in the treatment of liver metastases. Cancer Res. 100:1986;298-304.
19. Byfield J.E., Calabro-Jones P., Klisak I., Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x rays. Int. J. Radiat. Oncol. Biol. Phys. 8:1982;1923-1933.
20. Parker W.B., Cheng Y.C. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther. 48:1990;381-395.
21. Smalley S.R., Kimler B.F., Evans R.G. 5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;207-211.
22. von der Maase H. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumour. Radiother. Oncol. 7:1986;47-68.
23. Weckbecker G. Biochemical parmacology and analysis of fluoropyrimidines alone and in combination with modulators. Pharmac. Ther. 50:1991;367-424.
24. 14C in mouse, rat, rabbit, dog and man. Chemotherapy. 22:1976;137-153.